(Q40385226)

20 September 2017

1 reference

title

Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin (English)

1 reference

20 September 2017

0 references

1 reference

0 references

Bianco S

1

1 reference

20 September 2017

Robuschi M

2

1 reference

20 September 2017

Petrigni G

3

1 reference

20 September 2017

Scuri M

4

1 reference

20 September 2017

Pieroni MG

5

1 reference

20 September 2017

Refini RM

6

1 reference

20 September 2017

Vaghi A

7

1 reference

20 September 2017

Sestini PS

8

1 reference

20 September 2017

1 January 1993

1 reference

20 September 2017

1 reference

20 September 2017

46 Suppl 1

1 reference

20 September 2017

115-120

1 reference

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis

20 September 2017

1 reference

12 December 2020

The cyclooxygenase theory of aspirin-induced asthma.

1 reference

12 December 2020

Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients

1 reference

12 December 2020

Mucosal inflammation in asthma

1 reference

12 December 2020

Damage of the airway epithelium and bronchial reactivity in patients with asthma

1 reference

12 December 2020

The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma

1 reference

12 December 2020

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

12 December 2020

Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig

1 reference

12 December 2020

Analgesics, allergy and asthma

1 reference

12 December 2020

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

1 reference

12 December 2020

Pharmacotherapy of childhood asthma. An inflammatory disease

1 reference

12 December 2020

Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients

1 reference

12 December 2020

Anti-inflammatory drugs in the treatment of allergic disease

1 reference

12 December 2020

Effects of inhibition of thromboxane A2 synthesis in aspirin-induced asthma.

1 reference

12 December 2020

Anti-inflammatory therapies

1 reference

12 December 2020

Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin

1 reference

12 December 2020

Urinary leukotriene E4 in bronchial asthma

1 reference

12 December 2020

Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma

1 reference

12 December 2020

Aspirin sensitivity in asthmatics.

1 reference

12 December 2020

Identifiers

1 reference